Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Guangdong Zhongsheng Pharmaceutical Co Ltd (Zhongsheng Pharma) is a pharmaceutical company that carries out the research, development, production, and marketing. The company offers traditional Chinese medicine, chemical drugs, Chinese medicinal materials and processed slices, and chemical raw materials. Its main activities include drug production, commissioned drug production, wholesale, and retail of pharmaceutical products. The company offers a range of technical services, including technical development, consultation, exchanges, technology transfer, and promotion, alongside medical research and experimental development. It serves various industries, providing pharmaceutical solutions for different applications. Zhongsheng Pharma is headquartered in Dongguan, China.
Headquarters
China
Address
Information Industrial Park, Xihu Industrial Zone, Shilong Town, Dongguan, Guangdong, 523325
Website
www.zspcl.com
Telephone
86 769 86188130
No of Employees
1,757
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
002317 (SHE)
Revenue (2024)
$351.0M
-5.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-213.6%
(2024 vs 2023)
Market Cap*
$3.5B
Net Profit Margin (2023)
XYZ
-220.2%
(2024 vs 2023)
* As of and is in US$
Guangdong Zhongsheng Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Traditional Chinese Medicine | Technical |
| Chemical Drugs | Technical Development |
| Chinese Medicinal Materials and Processed Slices | Consultation |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In October, the company signed a partnership with Sinovac Biotech Ltd. to distribute Angladivir Tablets in Macao, China. |
| 2019 | Acquisitions/Mergers/Takeovers | In April, the company acquired 48.54% equity in Yikang Chinese Medicine Co., Ltd. |
| 2017 | Acquisitions/Mergers/Takeovers | In November, the company agreed to purchase 80% stake in Xuancheng eye hospital. |
Competitor Comparison
| Key Parameters | Guangdong Zhongsheng Pharmaceutical Co Ltd | Hubei Jumpcan Pharmaceutical Co Ltd | Henan Lingrui Pharmaceutical Co Ltd | Guizhou Bailing Group Pharmaceutical Co Ltd | Shanxi Zhendong Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Dongguan | Taizhou | Xinyang | Anshun | Changzhi |
| State/Province | Guangdong | Jiangsu | Henan | Guizhou | Shanxi |
| No. of Employees | 1,757 | 4,137 | 2,789 | 5,715 | 3,695 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Chen Yonghong | Chairman; President | Executive Board | 2016 | 56 |
| Zhang Yuchong | Senior Vice President; Vice Chairman | Executive Board | 2019 | 37 |
| Long Chunhua | Director; Vice President; Chief Financial Officer | Executive Board | 2014 | 54 |
| Chen Xiaoxin | Vice President | Senior Management | 2025 | 47 |
| Luo Rikang | Vice President | Senior Management | 2024 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer